Immunology and Microbiology
Aortic Smooth Muscle Cell
100%
Cell Culture
33%
Downregulation
100%
Kinase A
66%
Northern Blotting
33%
Pretreatment
100%
Smooth Muscle Cell
66%
Steady State
33%
Western Blot
33%
Zaprinast
100%
Keyphrases
Cell Culture Model
8%
Co-incubation
8%
Concentration-dependent
8%
Cyclic GMP
58%
Distinct Mechanism
8%
Dose Effect
8%
Early Onset
8%
Human Aortic Smooth muscle Cells (HASMCs)
100%
Incubation
8%
Intact Cells
8%
MRNA Level
8%
Northern Blot Analysis
8%
Oxyhemoglobin
8%
Phosphodiesterase Inhibitors
16%
Possible Mechanisms
8%
Protein Kinase
16%
Protein Level
16%
Reducing Agent
16%
S-nitroso-N-acetylpenicillamine
16%
Sensitive Business Process
8%
Smooth muscle Cells
16%
Sodium Nitroprusside
100%
Soluble Guanylate Cyclase
33%
Steady State
8%
Thiols
8%
Tolerance Mechanisms
100%
Western Blot Analysis
8%
Zaprinast
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cell Culture
8%
Cyclic AMP Dependent Protein Kinase
8%
Cyclic AMP Dependent Protein Kinase Inhibitor
8%
Cyclic GMP
58%
Guanylate Cyclase
33%
H-89
16%
Messenger RNA
8%
Nitroprusside Sodium
100%
Oxyhemoglobin
8%
Phosphodiesterase Inhibitor
16%
Reducing Agent
16%
S-Nitroso-N-Acetylpenicillamine
16%
Thiol
8%
Western Blot
8%
Zaprinast
25%
Neuroscience
Cell Culture
8%
Cyclic Guanosine Monophosphate
58%
Guanylate Cyclase
33%
H-89
16%
Messenger RNA
8%
Northern Blot
8%
Oxyhemoglobin
8%
Phosphodiesterase Inhibitor
16%
Protein Kinase A
16%
Reducing Agent
16%
Sodium Nitroprusside
100%
Thiol
8%
Western Blot
8%
Zaprinast
25%